The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Digital transformation links Africa, Brazil, Arabs
- Qatar foundation, FGV, OECD unite educators
- External outlook challenging for Egyptian economy
- UAE minister optimistic regarding Mercosur
- G20: leaders cite concerns over Gaza and Lebanon
- Tunisia presents Mediterranean action at COP29
- Oman polymer park seeks Brazilian companies
- Qatar’s emir attends G20 in Rio de Janeiro
